Generic name: anifrolumab-fnia
Dosage form: injection, for intravenous use
Drug class:Selective immunosuppressants
What is Saphnelo?
- Saphnelo is a prescription medicine used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.
- Saphnelo contains anifrolumab-fnia which is in a group of medicines called monoclonal antibodies. Lupus is a disease of the immune system (the body system that fights infection). When given together with other medicines for lupus, Saphnelo may help to reduce your lupus disease activity more than other lupus medicines alone.
- It is not known if this medicine is effective in people with severe active lupus nephritis or central nervous system lupus.
- It is not known if this medicine is safe and effective in children under 18 years of age.
Who should not use Saphnelo?
Do not use Saphnelo if you are allergic to anifrolumab-fnia or any of the ingredients in the injection. See the end of this page for a complete list of ingredients.
Before receiving Saphnelo
Before you receive Saphnelo, tell your healthcare provider about all of your medical conditions, including if you:
- think you have an infection or have infections that keep coming back. You should not receive Saphnelo if you have an infection unless your healthcare provider tells you to.
- are scheduled to receive a vaccination or if you think you may need a vaccination. You should not receive live vaccines during treatment with Saphnelo.
- have or have had any type of cancer.
- are receiving other biologic medicines or monoclonal antibodies.
- are pregnant or plan to become pregnant. It is not known if Saphnelo will harm your unborn baby. Tell your healthcare provider if you are pregnant, think you might be pregnant, or plan to become pregnant during your treatment.
- Pregnancy..
